Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in … https://t.co/aAJIPTHKi9
— Greenfields Health Services (@greenfieldshs) September 18, 2018
https://platform.twitter.com/widgets.js
from Twitter https://twitter.com/greenfieldshs
September 18, 2018 at 07:56AM